N/A
N=37
Administration Method of Cognitive Screening in Older Individuals With Hearing Loss
Hearing Loss, Sensorineural · Cognitive Impairment
Bottom Line
View on ClinicalTrials.gov: NCT03402932 ↗Enrolled (actual)
37
Serious AEs
—
Results posted
Apr 2019
Primary outcome: Primary: Cognitive Screening Results (Montreal Cognitive Assessment) — 28.69; 22.37; 23.375; 23 score on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Auditory amplified (Other); Visual (Other); Auditory unamplified (Other)
- Age
- Adult, Older Adult · 60+ yrs
- Sex
- All
- Sponsor
- Northwestern University
- Primary completion
- Jul 2018
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Cognitive Screening Results (Montreal Cognitive Assessment) |
28.69; 22.37; 23.375; 23; 28.30; 23.5 | — |
| SECONDARY Auditory Working Memory Performance |
82.88; 72.3; 69.1; 57.5; 82.11; 66.9 | — |
Summary
The objectives of the current project aim to determine whether a more controlled amplification method or a visual administration has an effect on hearing impaired older individuals' cognitive test scores.
Eligibility Criteria
Inclusion Criteria
- Have sensorineural hearing loss
- Have normal or corrected-to-normal vision
Exclusion Criteria
- Have conductive hearing loss;
- Have history of otologic or neurologic disorders
- Have dementia
- Non-native speakers of English
Data sourced from ClinicalTrials.gov (NCT03402932). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.